3D Bioprinting Market by Technology (Microextrusion  Inkjet  Laser  Magnetic)  Material (Cells  Hydrogels  Extracellular Matrices  Biomaterials)  Application (Clinical (Bone  Cartilage  Skin) & Research (Regenerative Medicine)) - Global Forecasts to 2021

3D Bioprinting Market by Technology (Microextrusion Inkjet Laser Magnetic) Material (Cells Hydrogels Extracellular Matrices Biomaterials) Application (Clinical (Bone Cartilage Skin) & Research (Regenerative Medicine)) - Global Forecasts to 2021

MarketsandMarkets | ID: 1541225414698 | Published at: 2017-02-01 | Pages: 145

  • €4.821,70


The 3D bioprinting market is expected to reach USD 1,332.6 million by 2021, at a CAGR of 26.5% from 2016 to 2021.

The 3D bioprinting market is primarily driven by the rising demand for organ transplantation across the globe. In addition, growing R&D in the field of 3D bioprinting, increasing public and private investments to support 3D bioprinting research, and rising use of 3D bioprinting in drug discovery are supporting the growth of this market. On the other hand, limitations of biomaterial-based products and socio-ethical concerns are the major challenges in this market.

In this report, the 3D bioprinting market has been segmented on the basis of technology, applications (clinical and research applications), materials (living cells, hydrogels, extracellular matrices, and other biomaterials), and regions (North America, Europe, APAC, and the RoW). By technology, the global 3D bioprinting market is segmented into four categories, namely, microextrusion, laser-assisted, inkjet, and magnetic 3D bioprinting. The microextrusion 3D bioprinting market is estimated to command the largest share of the global market in 2016, due to its high affordability and simple setup process.

Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the 3D bioprinting market in 2016, followed by Europe. Increasing government initiatives and rising demand for organ transplants are the major factors driving market growth in North America. However, the presence of a stringent regulatory process for the approval of 3D bioprinting products is a major factor restraining the growth of this regional segment.

The 3D bioprinting market consists of a number of big, medium-sized, and small companies. As of 2015, the syringes market is dominated by Organovo Holdings Inc. (U.S.), EnvisionTEC GmbH (Germany), and Nano3D Biosciences, Inc. (U.S.). Product launches, development, and commercialization; agreements; collaboration; and partnerships were the major strategies adopted by most of the market players between 2013 and 2016 to achieve growth in the 3D bioprinting market.

Research Coverage
This report studies the 3D bioprinting market based on technology, application, and material. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:
This research report focuses on various levels of analysis—industry trends, market ranking of top players, and company profiles—which together discuss basic views on the competitive landscape, emerging and high-growth segments of the 3D bioprinting market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening its market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on products and services offered by major players in the 3D bioprinting market. The report analyzes the 3D bioprinting market based on technology, application, material, and region

• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the 3D bioprinting market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various 3D bioprinting products across geographies

• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the 3D bioprinting market

• Competitive Assessment: In-depth assessment of market shares, strategies, products & services, distribution networks, and manufacturing capabilities of leading players in the 3D bioprinting market

TABLE OF CONTENTS

1 INTRODUCTION 14

  • 1.1 OBJECTIVES OF THE STUDY 14
  • 1.2 MARKET DEFINITION 15
  • 1.3 MARKET SCOPE 15
  • 1.4 MARKETS COVERED 15
  • 1.5 YEARS CONSIDERED FOR THE STUDY 16
  • 1.6 CURRENCY 16
  • 1.7 LIMITATIONS 16
  • 1.8 STAKEHOLDERS 17
    2 RESEARCH METHODOLOGY 18
  • 2.1 RESEARCH METHODOLOGY STEPS 18
    • 2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 19
      • 2.1.1.1 Secondary research 19
      • 2.1.1.2 Key data from secondary sources 19
      • 2.1.1.3 Primary research 20
      • 2.1.1.4 Key data from primary sources 21
      • 2.1.1.5 Key Industry Insights 22
  • 2.2 MARKET SIZE ESTIMATION METHODOLOGY 22
  • 2.3 RESEARCH DESIGN 24
  • 2.4 MARKET DATA VALIDATION AND TRIANGULATION 25
  • 2.5 ASSUMPTIONS FOR THE STUDY 26
    3 EXECUTIVE SUMMARY 27
  • 3.1 INTRODUCTION 27
  • 3.2 CONCLUSION 31
    4 PREMIUM INSIGHTS 32
  • 4.1 3D BIOPRINTING: MARKET OVERVIEW 32
  • 4.2 GEOGRAPHIC ANALYSIS: 3D BIOPRINTING MARKET, BY TECHNOLOGY (2016) 33
  • 4.3 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2016 VS. 2021 (USD MILLION) 33
  • 4.4 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2016 VS. 2021 (USD MILLION) 34
  • 4.5 GEOGRAPHIC SNAPSHOT OF THE 3D BIOPRINTING MARKET 34
    5 MARKET OVERVIEW 35
  • 5.1 INTRODUCTION 36
  • 5.2 MARKET DYNAMICS 36
    • 5.2.1 DRIVERS 37
      • 5.2.1.1 Growing demand for organ transplantation 37
      • 5.2.1.2 Rise in public and private funding to support 3D bioprinting research activities 37
      • 5.2.1.3 Increasing use of 3D bioprinting in the drug discovery process 38
      • 5.2.1.4 Growing focus of market players on 3D bioprinting 38
    • 5.2.2 RESTRAINTS 39
      • 5.2.2.1 Lack of regulatory guidelines governing 3D bioprinting 39
      • 5.2.2.2 Dearth of trained professionals 39
    • 5.2.3 OPPORTUNITIES 40
      • 5.2.3.1 Increasing stem cell research 40
      • 5.2.3.2 Growing awareness related to 3D bioprinting 41
      • 5.2.3.3 Rising adoption of 3D bioprinting in the cosmetic industry 41
    • 5.2.4 CHALLENGES 42
      • 5.2.4.1 Socio-ethical concerns related to the use of 3D bioprinted products 42
      • 5.2.4.2 Limitations of biomaterial-based products 42
      • 5.2.4.3 Lack of complete automation 42
        6 INDUSTRY INSIGHTS 43
  • 6.1 INTRODUCTION 43
  • 6.2 3D BIOPRINTING APPROACHES 43
    • 6.2.1 BIOMIMICRY 43
    • 6.2.2 AUTONOMOUS SELF-ASSEMBLY 43
    • 6.2.3 MINI-TISSUE BUILDING BLOCKS 43
  • 6.3 3D BIOPRINTING PATENT LANDSCAPE 44
  • 6.4 INDUSTRY TRENDS 45
    • 6.4.1 FUNDING AND INVESTMENTS 45
    • 6.4.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 45
    • 6.4.3 CONFERENCES AND SYMPOSIUMS 46
      7 3D BIOPRINTING MARKET, BY TECHNOLOGY 47
  • 7.1 INTRODUCTION 48
  • 7.2 MAGNETIC 3D BIOPRINTING 49
  • 7.3 LASER-ASSISTED BIOPRINTING 50
  • 7.4 INKJET 3D BIOPRINTING 52
  • 7.5 MICROEXTRUSION BIOPRINTING 54
    8 3D BIOPRINTING MARKET, BY MATERIAL 56
  • 8.1 INTRODUCTION 57
  • 8.2 HYDROGELS 58
  • 8.3 EXTRACELLULAR MATRICES 59
  • 8.4 LIVING CELLS 61
  • 8.5 OTHER BIOMATERIALS 62

9 3D BIOPRINTING MARKET, BY APPLICATION 64

  • 9.1 INTRODUCTION 65
  • 9.2 CLINICAL APPLICATIONS 66
    • 9.2.1 SKIN 68
    • 9.2.2 BONE & CARTILAGE 69
    • 9.2.3 BLOOD VESSELS 69
  • 9.3 RESEARCH APPLICATIONS 70
    • 9.3.1 DRUG RESEARCH 72
    • 9.3.2 REGENERATIVE MEDICINE 73
    • 9.3.3 3D CELL CULTURE 73
      10 3D BIOPRINTING MARKET, BY REGION 75
  • 10.1 INTRODUCTION 76
  • 10.2 NORTH AMERICA 78
    • 10.2.1 U.S. 80
    • 10.2.2 CANADA 83
  • 10.3 EUROPE 85
    • 10.3.1 GERMANY 87
    • 10.3.2 FRANCE 89
    • 10.3.3 U.K. 91
    • 10.3.4 REST OF EUROPE (ROE) 93
  • 10.4 ASIA-PACIFIC 95
    • 10.4.1 JAPAN 97
    • 10.4.2 CHINA 99
    • 10.4.3 INDIA 101
    • 10.4.4 REST OF ASIA-PACIFIC 103
  • 10.5 REST OF THE WORLD (ROW) 105
    11 COMPETITIVE LANDSCAPE 107
  • 11.1 OVERVIEW 107
  • 11.2 MARKET RANKING ANALYSIS 108
  • 11.3 COMPETITIVE SITUATION AND TRENDS 109
    • 11.3.1 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS 109
    • 11.3.2 PRODUCT LAUNCHES, DEVELOPMENTS, AND COMMERCIALIZATION 110
    • 11.3.3 PRODUCT SHOWCASES, EXHIBITIONS, AND PRESENTATIONS 111
    • 11.3.4 FUNDING 112
    • 11.3.5 OTHER STRATEGIES 113

12 COMPANY PROFILES 114
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1 INTRODUCTION 114
  • 12.2 ORGANOVO HOLDINGS, INC. 115
  • 12.3 ENVISIONTEC GMBH 119
  • 12.4 NANO3D BIOSCIENCES, INC. 121
  • 12.5 CYFUSE BIOMEDICAL K.K. 124
  • 12.6 REGENHU LTD. 126
  • 12.7 ASPECT BIOSYSTEMS LTD. 127
  • 12.8 BIOBOTS 128
  • 12.9 CELLINK 129
  • 12.10 GESIM 130
  • 12.11 POIETIS 131
  • 12.12 REGENOVO BIOTECHNOLOGY CO., LTD. 133
  • 12.13 3DYNAMIC SYSTEMS LTD. 134

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 135

  • 13.1 DISCUSSION GUIDE 135
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 138
  • 13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 140
  • 13.4 AVAILABLE CUSTOMIZATIONS 141
  • 13.5 RELATED REPORTS 142
  • 13.6 AUTHOR DETAILS 143

LIST OF TABLES

TABLE 1 3D BIOPRINTING PATENTS, 2015–2016 44
TABLE 2 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION) 48
TABLE 3 MAGNETIC 3D BIOPRINTING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 50
TABLE 4 LASER-ASSISTED 3D BIOPRINTING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 51
TABLE 5 INKJET 3D BIOPRINTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 53
TABLE 6 MICROEXTRUSION 3D BIOPRINTING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 55
TABLE 7 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014-2021 (USD MILLION) 57
TABLE 8 HYDROGELS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 59
TABLE 9 EXTRACELLULAR MATRICES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 60
TABLE 10 LIVING CELLS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 62
TABLE 11 OTHER BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 63
TABLE 12 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 65
TABLE 13 CLINICAL APPLICATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 66
TABLE 14 CLINICAL APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 67
TABLE 15 SKIN BIOPRINTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 68
TABLE 16 BONE & CARTILAGE BIOPRINTING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 69
TABLE 17 BLOOD VESSEL BIOPRINTING MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 70
TABLE 18 RESEARCH APPLICATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 71
TABLE 19 RESEARCH APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 71
TABLE 20 DRUG RESEARCH MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 72
TABLE 21 REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 73
TABLE 22 3D CELL CULTURE MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 74
TABLE 23 3D BIOPRINTING MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 77
TABLE 24 NORTH AMERICA: 3D BIOPRINTING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 78
TABLE 25 NORTH AMERICA: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 78
TABLE 26 NORTH AMERICA: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 80
TABLE 27 NORTH AMERICA: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 80
TABLE 28 U.S.: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 82
TABLE 29 U.S.: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 82
TABLE 30 U.S.: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 82
TABLE 31 CANADA: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 83
TABLE 32 CANADA: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 84
TABLE 33 CANADA: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 84
TABLE 34 EUROPE: 3D BIOPRINTING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 85
TABLE 35 EUROPE: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 85
TABLE 36 EUROPE: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 87
TABLE 37 EUROPE: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 87
TABLE 38 GERMANY: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 88
TABLE 39 GERMANY: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 88
TABLE 40 GERMANY: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 89
TABLE 41 FRANCE: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 90
TABLE 42 FRANCE: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 90
TABLE 43 FRANCE: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 90
TABLE 44 U.K.: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 92
TABLE 45 U.K.: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 92
TABLE 46 U.K.: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 92
TABLE 47 ROE: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 94
TABLE 48 ROE: 3D BIOPRINTING MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 94
TABLE 49 ROE: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 94
TABLE 50 ASIA-PACIFIC: 3D BIOPRINTING MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 95
TABLE 51 ASIA-PACIFIC: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 95
TABLE 52 ASIA-PACIFIC: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 97
TABLE 53 ASIA-PACIFIC: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 97
TABLE 54 JAPAN: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 98
TABLE 55 JAPAN: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 98
TABLE 56 JAPAN: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 99
TABLE 57 CHINA: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 100
TABLE 58 CHINA: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 100
TABLE 59 CHINA: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 100
TABLE 60 INDIA: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 101
TABLE 61 INDIA: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 102
TABLE 62 INDIA: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 102
TABLE 63 ROAPAC: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 103
TABLE 64 ROAPAC: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 104
TABLE 65 ROAPAC: 3D BIOPRINTING MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 104
TABLE 66 ROW: 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 106
TABLE 67 ROW: 3D BIOPRINTING MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 106
TABLE 68 ROW: 3D BIOPRINTING MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 106
TABLE 69 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2016 109
TABLE 70 TOP 5 PRODUCT LAUNCHES, DEVELOPMENTS, AND COMMERCIALIZATION,
2013–2016 110
TABLE 71 PRODUCT SHOWCASES, EXHIBITIONS, AND PRESENTATIONS, 2013–2016 111
TABLE 72 TOP 5 FUNDING, 2013–2016 112
TABLE 73 OTHER STRATEGIES, 2013–2016 113
TABLE 74 PRODUCT MIX OF THE 3D BIOPRINTER MARKET PLAYERS 114


LIST OF FIGURES

FIGURE 1 GLOBAL 3D BIOPRINTING MARKET: RESEARCH METHODOLOGY STEPS 18
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
FIGURE 3 RESEARCH METHODOLOGY: BOTTOM-UP APPROACH 23
FIGURE 4 RESEARCH METHODOLOGY: TOP-DOWN APPROACH 23
FIGURE 5 DATA TRIANGULATION METHODOLOGY 24
FIGURE 6 DATA TRIANGULATION METHODOLOGY 25
FIGURE 7 GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY 28
FIGURE 8 GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION 28
FIGURE 9 GLOBAL 3D BIOPRINTING MARKET, BY MATERIAL 29
FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE GLOBAL 3D BIOPRINTING MARKET 30
FIGURE 11 RISING DEMAND FOR ORGAN TRANSPLANTATION IS DRIVING GROWTH IN THE 3D BIOPRINTING MARKET 32
FIGURE 12 MICROEXTRUSION 3D BIOPRINTING TO DOMINATE THE GLOBAL 3D BIOPRINTING MARKET IN 2016 33
FIGURE 13 LIVING CELLS TO COMMAND THE LARGEST SHARE IN THE 3D BIOPRINTING MARKET IN 2016 33
FIGURE 14 RESEARCH APPLICATIONS WILL CONTINUE TO DOMINATE THE GLOBAL 3D BIOPRINTING MARKET IN 2021 34
FIGURE 15 NORTH AMERICA TO COMMAND THE LARGEST SHARE IN THE GLOBAL 3D BIOPRINTING MARKET IN 2016 34
FIGURE 16 3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36
FIGURE 17 MICROEXTRUSION 3D BIOPRINTING SEGMENT TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD 48
FIGURE 18 ASIA-PACIFIC TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD 49
FIGURE 19 NORTH AMERICA TO HOLD A MAJOR SHARE IN THE LASER-ASSISTED 3D BIOPRINTING MARKET 51
FIGURE 20 ASIA-PACIFIC TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD 53
FIGURE 21 NORTH AMERICA TO HOLD A MAJOR SHARE IN THE MICROEXTRUSION 3D BIOPRINTING MARKET 54
FIGURE 22 LIVING CELLS SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD 57
FIGURE 23 NORTH AMERICA TO HOLD THE LARGEST SHARE IN THE HYDROGELS MARKET, IN 2016 AND 2021 58
FIGURE 24 ASIA-PACIFIC SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD 60
FIGURE 25 NORTH AMERICA TO HOLD THE LARGEST SHARE IN THE LIVING CELLS MARKET DURING THE FORECAST PERIOD 61
FIGURE 26 NORTH AMERICA TO HOLD LARGEST SHARE OF THE OTHER BIOMATERIALS MARKET IN 2016 63
FIGURE 27 RESEARCH APPLICATIONS SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 65
FIGURE 28 SKIN SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD 66
FIGURE 29 NORTH AMERICA TO COMMAND LARGEST SHARE DURING THE FORECAST PERIOD 67
FIGURE 30 DRUG RESEARCH SEGMENT TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD 70
FIGURE 31 ASIA-PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD 71
FIGURE 32 3D BIOPRINTING MARKET: GROWTH FORECAST, BY REGION (2016–2021) 76
FIGURE 33 NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT 79
FIGURE 34 EUROPE: 3D BIOPRINTING MARKET SNAPSHOT 86
FIGURE 35 APAC: 3D BIOPRINTING MARKET SNAPSHOT 96
FIGURE 36 LEADING MARKET PLAYERS ADOPTED AGREEMENT, COLLABORATION, AND PARTNERSHIP AS THEIR KEY GROWTH STRATEGY OVER THE LAST THREE YEARS (2013–2016) 107
FIGURE 37 GLOBAL 3D BIOPRINTING MARKET RANKING, BY KEY PLAYER, 2015 108
FIGURE 38 BATTLE FOR MARKET SHARE: AGREEMENT, COLLABORATION, AND PARTNERSHIP WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS 109
FIGURE 39 COMPANY SNAPSHOT: ORGANOVO HOLDINGS, INC. 115

Get in touch!

Looking for sample pages? Or want to speak to someone about discounts?

Please leave your details and we'll get back to you as soon as we can!